
Sign up to save your podcasts
Or


Our co-hosts discuss the currently active & accruing NRG-GI008 study, also known as the "CIRCULATE-NORTH AMERICA" study. This study will evaluate what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
By NRG Oncology5
1010 ratings
Our co-hosts discuss the currently active & accruing NRG-GI008 study, also known as the "CIRCULATE-NORTH AMERICA" study. This study will evaluate what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

228,867 Listeners

6,769 Listeners

30,798 Listeners

8,765 Listeners

523 Listeners

29,685 Listeners

2,440 Listeners

112,451 Listeners

9,558 Listeners

62 Listeners

10,019 Listeners

16,001 Listeners

2,186 Listeners

38 Listeners

5 Listeners